Aaron Aday is a Cardiology physician. ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 The Vanderbilt Clinic
Nashville, TN 37232
Telephone
615-322-3000Provider last certified this registry record 23 Mar 2022.
Clinical trials
- Survey on Physical Activity and Qualify of Life in Fibromuscular Dysplasia
Sponsor: Vanderbilt University Medical Center
- Best Practice Advisory to Initiate High-Intensity Statin Therapy in Patients With Peripheral Artery Disease
Sponsor: Vanderbilt University Medical Center
- The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
Sponsor: Vanderbilt University Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202517 payments$10,792openpaymentsdata.cms.gov ↗
- TACTILE SYSTEMS TECHNOLOGY INCProgram year20251 payment
- Tactile Systems Technology IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2020–2025 per NIH RePORTER. The latest:
- The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease
Vanderbilt University Medical Center
FY2025$185,436K23HL151871 - The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease
Vanderbilt University Medical Center
FY2024$185,436K23HL151871 - The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease
Vanderbilt University Medical Center
FY2023$185,436K23HL151871
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”